Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris

International Journal of Dermatology

Volumn 44, Issue 3, 2005, Pages 248-251

  Kus, Sadiye ^a   Gün, Dilek ^a,b   Demirçay, Zeynep ^a   Sur, Haydar ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Health Education Faculty ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ISOTRETINOIN; LIPID; LIVER ENZYME; PETROLATUM;

ACNE VULGARIS; ADULT; ARTHRALGIA; ARTICLE; CHEILITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRY SKIN; ENZYME BLOOD LEVEL; EPISTAXIS; ERYTHEMA; EYE IRRITATION; FACE DISORDER; FEMALE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEADACHE; HUMAN; INCIDENCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MYALGIA; PYOGENIC GRANULOMA; RANDOMIZED CONTROLLED TRIAL; SKIN BRUISING; SKIN DISEASE;

ACNE VULGARIS; ADOLESCENT; ADULT; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; MALE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; VITAMIN E;

EID: 15844363884     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02072.x     Document Type: Article

References (14)

1. Layton MA, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 1992; 27: S2-S7.
2. Goulden V, Layton MA, Cunliffe WJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994; 131: 360-363.
3. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45: S150-S157.
4. Saurat JH. Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27: S23-S28.
5. DiPaola RS, Weiss RE, Cummings KB, et al. Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen. Clin Cancer Res 1997; 3: 1999-2004.
6. Nikolaou AC, Fountzilas G, Daniilidis I. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study. J Laryngol Otol 1996; 110: 857-861.
7. Look KY, Blessing JA, Nelson BE, et al. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Clin Oncol 1998; 21: 591-594.
8. Besa EC, Abrahm JL, Bartholomew MJ, et al. Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol. Am J Med 1990; 89: 739-747.
9. Dimery IW, Hong WK, Lee JJ, et al. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann Oncol 1997; 8: 85-89.
10. Cunliffe WJ, van de Kerkhof PC, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351-357.
11. Pochi PE, Shalita AR, Strauss JS, et al. Report of the Consensus Conference on Acne Classification. Washington, D.C. March 24 and 25 1990. J Am Acad Dermatol 1991; 24: 495-500.
12. Pryor WA. Vitamin E. Carotenoid Abstracts. Illinois: Veris, 1997: 7-11.
13. Strauss JS, Gottlieb AB, Jones T, et al. Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial. J Am Acad Dermatol 2000; 43: 777-784.
14. Asilian A, Omidghaemi MR, Momeni A. Concomitant administration of vitamin E does not change the side effects of acitretin: a randomised controlled study. Retinoids 2002; 18: 6-8.